Evaluation of the diagnostic value of chemokine and cytokine biomarkers and their role in the pathogenesis of autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC)

评估趋化因子和细胞因子生物标志物的诊断价值及其在自身免疫性肝炎（AIH）、原发性胆汁性肝硬化（PBC）和原发性硬化性胆管炎（PSC）发病机制中的作用

• 批准号: 270569
• 负责人: Landi Abdolamir
• 金额: $ 3.28万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-10-01 至 2014-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=270569&lang=en
• 关键词: & Immunohistochemistry; Animal Models & Therapeutic Intervention; Autoimmune Hepatitis & Pathogenesis; Cell Cultures; Cellular Immunology & Flow Cytometry; Chemokines & Receptors; Cytokines; Dna/Rna Purification & Rt-Pcr; Gasteroenterology & Hepatology; I

Primary sclerosing cholangitis (PSC), primary biliary cirrhosis (PBC), and autoimmune hepatitis (AIH) are three common chronic inflammatory liver diseases (combined prevalence of ~1/1000) that account for a significant number of liver transplantations in

原发性硬化性胆管炎（PSC）、原发性胆汁性肝硬化（PBC）和自身免疫性肝炎（AIH）是三种常见的慢性炎症性肝病（合计患病率约为1/1000），在中国的肝移植中占相当大的比例